Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value
$555.05M
Total Bought
$894.6K
Total Sold
$16.07M
Net Transaction
-$15.17M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,1830162,699213,91238.54%+51,212
Nanobiotix S.A.(NBTX)5,623,8165,623,8160106,234130,02323.43%+23,789
Xencor, Inc.(XNCR)748,062748,06208,77511,4532.06%+2,678
Rapport Therapeutics, Inc.(RAPP)1,784,5171,784,517053,00054,1429.75%+1,142
Lyell Immunopharma, Inc.(LYEL)54,88754,88708911,6890.30%+798
Vor Biopharma, Inc.(VOR)053,732+53,73207030.13%+703
Rallybio Corporation(RLYB)3,636,3633,636,36301,8152,4950.45%+680
Adicet Bio, Inc.022,779+22,77901920.03%+192
Standard BioTools, Inc.(LAB)311,967311,96704063990.07%-6
Senseonics Holdings, Inc.(SENS)54,6210-54,621240—-24
BiomX Inc.(PHGE)96,8660-96,866510—-51
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,44503,3663,3110.60%-55
Nano-X Imaging Ltd.
ORD SHS
158,852158,85205884450.08%-143
Adicet Bio, Inc.364,4720-364,4722950—-295
Contineum Therapeutics Inc.(CTNM)1,979,1731,979,173023,25522,6224.08%-633
Fate Therapeutics, Inc.(FATE)3,379,0643,379,06404,2583,3200.60%-937
Procept BioRobotics Corporation(PRCT)357,939357,939012,77511,2612.03%-1,514
MeiraGTx Holdings plc(MGTX)6,641,0646,641,064054,65652,7969.51%-1,859
Vor Biopharma, Inc.(VOR)53,7320-53,7322,6180—-2,618
CVRx, Inc.(CVRX)4,103,4304,024,861-78,56933,11528,5775.15%-4,538
Arrowhead Pharmaceuticals, Inc.(ARWR)247,5980-247,5988,5400—-8,540
Legend Biotech Corporation(LEGN)814,586814,586026,56417,7093.19%-8,855
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q4 2025 | TickerTrail